Abstract
Background: Delays at any stage of the breast cancer diagnostic process may result in high anxiety for the woman. Targets should be set at every stage where delay may arise. The aim of this study was to investigate the therapeutic delay in women with primarily operable breast cancer before and after the implementation of breast cancer rapid management policy (BCRMP) in our institution and compare it to the European Commission (EC) recommendations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
